Answers are grounded in this paper and cite their sources.
To determine if a recently licensed radioimmunoassay (Ausria-125) would further reduce the incidence of type B hepatitis, 139 presumably susceptible recipients were prospectively studied after they had received blood negative for hepatitis B antigen by counterelectrophoresis. Fifteen cases of icteric or anicteric hepatitis occurred, but only four could be attributed to hepatitis B. No hepatitis B occurred in nine subjects who received radioimmunoassay-positive blood alone, and only one in 10 who had received radioimmunoassay-positive and hepatitis-B-antigen-positive blood. Type B hepatitis developed in three of 120 patients who received radioimmunoassay-negative blood, If serologic responses only are compared, exposure to hepatitis B or hepatitis B antigen occurred in six of 19 recipients (31.6 per cent) of radioimmunoassay-positive blood. Only eight of 120 (6.7 per cent) responded among the recipients of radioimmunoassay-negative blood. These findings do not support proposals for universal compu...
No takes yet. Share an insight, caveat, or question.
Hollinger et al. (1973) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: